Oxadiazoles in Medicinal Chemistry

被引:529
|
作者
Bostrom, Jonas [1 ]
Hogner, Anders [1 ]
Llinas, Antonio [1 ]
Wellner, Eric [1 ]
Plowright, Alleyn T. [1 ]
机构
[1] AstraZeneca R&D, S-43183 Molndal, Sweden
关键词
DRUG-LIKE PROPERTIES; RECEPTOR ANTAGONISTS; CARBOXYLIC-ACIDS; DISCOVERY; 1,3,4-OXADIAZOLES; INHIBITORS; LIPOPHILICITY; PHARMACOLOGY; REPLACEMENTS; SELECTIVITY;
D O I
10.1021/jm2013248
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms. Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities. The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection. In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner. Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers. The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments). To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.
引用
收藏
页码:1817 / 1830
页数:14
相关论文
共 50 条
  • [21] Rational application of drug promiscuity in medicinal chemistry
    Mei, Yicheng
    Yang, Baowei
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (15) : 1835 - 1851
  • [22] Catalysis in medicinal chemistry
    Dreher, Spencer D.
    REACTION CHEMISTRY & ENGINEERING, 2019, 4 (09) : 1530 - 1535
  • [23] Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry
    Urge, Laszlo
    Alcazar, Jesus
    Huck, Lena
    Dorman, Gyorgy
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 87 - 147
  • [24] Physics and Its Interfaces with Medicinal Chemistry and Drug Design
    Santos, Ricardo N.
    Andricopulo, Adriano D.
    BRAZILIAN JOURNAL OF PHYSICS, 2013, 43 (04) : 268 - 280
  • [25] Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
    Gerges, A.
    Canning, U.
    CHEMMEDCHEM, 2024, 19 (09)
  • [26] Fragment-to-Lead Medicinal Chemistry Publications in 2018
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Jahnke, Wolfgang
    Johnson, Christopher N.
    Mortenson, Paul N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) : 4430 - 4444
  • [27] Cinnoline Scaffold-A Molecular Heart of Medicinal Chemistry?
    Szumilak, Marta
    Stanczak, Andrzej
    MOLECULES, 2019, 24 (12):
  • [28] Triazole: A New Perspective in Medicinal Chemistry and Material Science
    Bezerra Morais, Pedro Alves
    Javarini, Clara Lirian
    Valim, Thays Cardoso
    Francisco, Carla Santana
    de Freitas Ferreira, Lara Chaves
    Trancoso Bottocim, Ramon Ramires
    Cunha Neto, Alvaro
    Lacerda Junior, Valdemar
    CURRENT ORGANIC CHEMISTRY, 2022, 26 (18) : 1691 - 1702
  • [29] Recent developments of 2-aminothiazoles in medicinal chemistry
    Das, Debasis
    Sikdar, Papiya
    Bairagi, Moumita
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 89 - 98
  • [30] Pharmacodynamic-Pharmacokinetic Integration as a Guide to Medicinal Chemistry
    Gabrielsson, Johan
    Fjellstrom, Ola
    Ulander, Johan
    Rowley, Michael
    Van der Graaf, Piet H.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (04) : 404 - 418